5,6,7,8-Tetrahydro-1,6-naphthyridin-3-amine, 95.0%, 250mg

5,7-Dimethoxy-[1,2,4]triazolo[1,5-a]pyrimidin-2-amine, 95.0%, 1g

7-Bromo-1,2,3,4-tetrahydrocyclopenta[b]indole, 98%, 1g

(R)-3-AMINO-1-METHYL-PIPERIDINE DIHYDROCHLORIDE, 95.0%, 100g

Crisol de fusión 79 forma baja, 25 ml, 1, 10 Pieza(s)

6-Chloro-2-methylpyridin-3-ol, 95.0%, 5g

Tert-butyl (2R,3R)-3-hydroxy-2-methylpyrrolidine-1-carboxylate, 98%, 500mg

Polvo de antimonio, mínimo 99,5 %, aproximadamente malla 325, 100 g, envase de plástico.

1-Iodo-2,2-dimethylpropane, 98%, 25g

(2E)-3-(3-bromophenyl)-1-(2,5-dichlorophenyl)prop-2-en-1-one, 95.0%, 10g

(2S,5R)-1,5-dimethylpyrrolidine-2-carboxylic acid, 95.0%, 100mg

2-(3-(Trifluoromethyl)phenyl)ethanol, 95.0%, 5g

2-HYDROXY-1-(4-METHYLPIPERAZIN-1-YL)ETHANONE, 95.0%, 250mg